NCT04543838

Brief Summary

The objective of this study is to prospectively evaluate the therapeutic effectiveness of with blood pressure management using intraoperative neurophysiological monitoring with SSEP and EEG to reduce perioperative stroke. The central hypothesis is that perioperative stroke occurs from emboli in the setting of significant hypoperfusion resulting in ischemia, which leads to infarction. The impact of the proposed research is that, if significant SSEP and EEG changes can be used to identify cerebral perfusion, then timely therapeutic interventions to effectively reduce the impact of perioperative stroke can be directed.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 2, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 10, 2020

Completed
7 months until next milestone

Study Start

First participant enrolled

April 20, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 17, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 17, 2023

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

November 8, 2024

Completed
Last Updated

November 8, 2024

Status Verified

November 1, 2024

Enrollment Period

1.7 years

First QC Date

September 2, 2020

Results QC Date

June 18, 2024

Last Update Submit

November 6, 2024

Conditions

Keywords

Cardiac DiseaseIntraoperative HypertensionCardiac SurgeryIntraoperative StrokePerioperative HypertensionAcute Perioperative Covert StrokePerioperative Complication

Outcome Measures

Primary Outcomes (1)

  • Proportion of Patients With a New Clinical Stroke, New Overt Stroke, and Death

    Proportion of patients with a new clinical stroke, new overt stroke, and death will be abstracted from subject EMR.

    post-operative day 30

Secondary Outcomes (9)

  • Proportion of Patients With Cognitive Decline

    post-operative 1 year

  • Proportion of Patients With Transient Ischemic Attack

    post-operative 1 year

  • Proportion of Patients With Delirium

    post-operative 1 year

  • Proportion of Patients With Clinical Stroke

    post-operative 1 year

  • Proportion of Patients With Composite of Clinical Stroke

    post-operative 1 year

  • +4 more secondary outcomes

Study Arms (2)

Standard of Care

ACTIVE COMPARATOR

Control will include standard of care pain management during the postoperative period. Participants in this arm will not receive an Electroencephalogram (EEG) and Somatosensory evoked potentials (SSEP).

Other: Standard of Care BP management

EEG & SSEP monitoring

EXPERIMENTAL

Intervention will include standard of care pain management during the postoperative period. Participants in this arm will receive an Electroencephalogram (EEG) and Somatosensory evoked potentials (SSEP). EEG will be used to manage blood pressure.

Diagnostic Test: Intervention

Interventions

InterventionDIAGNOSTIC_TEST

Electroencephalogram (EEG) and Somatosensory evoked potentials (SSEP) intraoperative monitoring

EEG & SSEP monitoring

If blood pressure (BP) control is determined to be necessary, standard of care practices to manage it will be implemented

Standard of Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled for Cardiac surgery at UPMC
  • Patients who are 18 years of age or older at screening
  • Patients with the ability to provide written informed consent

You may not qualify if:

  • Patient who, as determined by the investigators, are noncompliant or unable to complete follow-up assessments
  • Patient with history of dementia or other cognitive impairment. History of dementia will be determined by medical record review.
  • Patients who, as determined by the investigators, are unable to complete the preoperative testing
  • Have an implanted medical electronic device
  • Have indwelling or implanted metal in their body that is not MRI-compatible
  • Have claustrophobia. This will be measured by utilizing the standard screening questionnaire for MRI.
  • Develop back pain when lying flat for more than 1 hour
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, 15213, United States

Location

MeSH Terms

Conditions

Heart Diseases

Condition Hierarchy (Ancestors)

Cardiovascular Diseases

Results Point of Contact

Title
Parthasarathy Thirumala, MD
Organization
UPMC

Study Officials

  • Parthasarathy Thirumala, MD, MS

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
single-blind
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized prospective single-blind clinical trial
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 2, 2020

First Posted

September 10, 2020

Study Start

April 20, 2021

Primary Completion

January 17, 2023

Study Completion

January 17, 2023

Last Updated

November 8, 2024

Results First Posted

November 8, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations